Cargando…
Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria
Heterologous immunity, when the memory T cell response elicited by one pathogen recognizes another pathogen, has been offered as a contributing factor for the high variability in coronavirus disease 2019 (COVID-19) severity outcomes. Here we demonstrate that sensitization with bacterial peptides can...
Autores principales: | Eggenhuizen, Peter J., Ng, Boaz H., Chang, Janet, Cheong, Rachel M.Y., Yellapragada, Anusha, Wong, Wey Y., Ting, Yi Tian, Monk, Julie A., Gan, Poh-Yi, Holdsworth, Stephen R., Ooi, Joshua D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829141/ https://www.ncbi.nlm.nih.gov/pubmed/35154139 http://dx.doi.org/10.3389/fimmu.2022.821595 |
Ejemplares similares
-
BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity
por: Eggenhuizen, Peter J., et al.
Publicado: (2021) -
Treg Enhancing Therapies to Treat Autoimmune Diseases
por: Eggenhuizen, Peter J., et al.
Publicado: (2020) -
Editorial: The Network of Inflammatory Mechanisms in Kidney Disease: Mechanism and New Therapeutic Agents
por: Nozaki, Yuji, et al.
Publicado: (2021) -
Developing Gram-negative bacteria for the secretion of heterologous proteins
por: Burdette, Lisa Ann, et al.
Publicado: (2018) -
The C3aR promotes macrophage infiltration and regulates ANCA production but does not affect glomerular injury in experimental anti-myeloperoxidase glomerulonephritis
por: Dick, Jonathan, et al.
Publicado: (2018)